FDA

The Centers for Medicare and Medicaid Services (CMS) is considering the inclusion of Novo Nordisk’s (NYSE:NVO) obesity drug Wegovy in its coverage for heart disease patients with obesity. What Happened: The CMS is reviewing the FDA's action to expand the use of Wegovy to reduce the risk of...

The credibility of the clinical trial results for an experimental Alzheimer’s drug has been called into question following a critical inspection report by the Food and Drug Administration (FDA). What Happened: The FDA report, which was released under the Freedom of Information Act,...

The Food and Drug Administration recently offered a glimpse into its comprehensive analysis justifying its recommendation to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. CDER director Patrizia Cavazzoni explained that as part of the FDA's “...

Expressing concern that President Joe Biden might backtrack on a proposal to avoid backlash from Black voters, a senior health official in the Biden administration is encouraging allies outside the government to press the White House to enact a nationwide ban on menthol cigarettes. Robert Califf,...

During a recent hearing on vaccine safety, Rep. Marjorie Taylor Greene (R-Ga.) made controversial statements that have drawn criticism from her Democratic colleagues. What Happened: Greene, who is not a medical professional, said, "I'm not a doctor, but I have a Ph.D. in recognizing bulls*...

The biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) reported its second quarter financial results on Tuesday for the three months ended Dec. 31, 2023, The company's primary focus is on developing therapy for acute cannabinoid intoxication (ACI). "Anebulo continues to make...

FDA Nods To Hemp Seed Meal Use for Laying Hens, Signaling Feed Breakthrough The Food & Drug Administration’s Center for Veterinary Medicine has approved a definition for “hemp seed meal” (HSM) for laying hens. This decision, a result of the Hemp Feed Coalition’s...

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares are trading higher Thursday after the company announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for DA-1726 for the treatment of obesity. The Details: NeuroBo announced that the FDA has...

The U.S. Department of Agriculture (USDA) has launched an initiative to survey hemp farmers across the nation. Aimed at gaining a deeper understanding of the industry’s growth and challenges, this move will gauge the current state and challenges of the rapidly evolving industry. USDA’s...

Following a preliminary review, the U.S. Food and Drug Administration found no evidence that weight-loss drugs cause suicidal thoughts. What To Know: Following reports of suicidal thoughts or actions, the FDA conducted a review of a class of popular weight-loss and diabetes drugs known as GLP-1 RAs...

A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves approximately 675,000 cans of infant formula. What Happened: Reckitt Benckiser Group plc‘s (OTC:RBGLY) Mead Johnson Nutrition (NYSE:MJN) is...

DeFloria LLC, a collaboration between Charlottes Web Holdings Inc (OTCQX:CWBHF) and AJNA BioSciences PBC, has launched the Phase 1 clinical trial of AJA001, a full-spectrum hemp botanical drug. The trial, which marks the first human testing of this innovative substance, began with dosing its first...

Nearly five years after the descheduling of hemp by Congress in 2018, the industry remains mired in uncertainty. A recent briefing hosted by the ONE HEMP coalition in Washington, DC, brought together leading voices advocating for a regulatory framework for hemp-derived CBD products. The coalition...

Logan Paul, the YouTube influencer turned WWE Superstar and co-founder of PRIME, came forward on Thursday in defense of the drink amid mounting criticism and possible government intervention. What Happened: PRIME drinks shot to fame among teens immediately upon the brand’s release, and...

Elon Musk's brain-implant company Neuralink has received the green light from the Food and Drug Administration to commence its "first-in-human clinical study." What Happened: This milestone achievement for Neuralink comes after a series of setbacks and challenges faced by the company in its pursuit...